RevolKa Ltd. Announces Milestone Achievement in Collaborative Research with Sumitomo Pharma Co., Ltd.

RevolKa Ltd., a biotech company, has announced the completion of its collaborative drug discovery project with Sumitomo Pharma Co. for rare diseases. The project was completed within the agreed time frame and lead candidates were identified using RevolKa's proprietary technology platform called aiProtein®, which integrates directed protein evolution technology with artificial intelligence (AI). ..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 26.
  • textsms

Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology

Biomerica Inc. has received a Notice of Allowance for a patent application that covers a development stage IT system from the China National Intellectual Property Administration. The system includes an artificial intelligence claim aimed at assisting individuals to protect themselves against potential adverse reactions to specific food ingredients and offers personalized approaches to dietary in..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 22.
  • textsms

70% of Major Pharmaceutical Companies and CROs Surveyed Have Adopted Digital Pathology

Proscia's new survey reveals that approximately 70% of life science organizations have invested in digital pathology to advance drug research and development. Over half of these organizations still use legacy software systems, primarily for basic image viewing, despite the growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics. The survey als..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 14.
  • textsms